Pharmacogenomics and stratified health care should ensure that patients are offered the 'right treatment, for the right person, at the right time’. This module will provide an overview of the analytical strategies and techniques used in pharmacogenomics and explore some of the challenges and limitations in this field. Biomarkers are the predictive tools for optimising drug response and preventing adverse drug reactions. Thus this module will also provide an overview of the different types of genomic biomarkers currently in use or emerging.
15 Masters level credits
Module attendance required
Teaching delivered one day each week for five consecutive weeks.
First iteration - January 2019
Second iteration - September 2019
The module will be assessed via a short presentation, a 3000-word essay assignment and short-answer/case study problems completed in your own time. For those taking the module as a stand-alone option, you need only take the assessment if you require the University credits.
Academics involved in the delivery of this module
Professor Gary Middleton (Professor of Medical Oncology, University of Birmingham and Honorary Consultant Medical Oncologist)
Dr Andrew Bell
Other University staff teaching:
NHS staff teaching:
- Dr Philippe Taniere
- Dr Rachel Webster
- Dr Adam Croft
- Dr Kully Sandhu
Dr Martin Pass (Astra Zeneca)
This module can be taken as a stand-alone assessed or non-assessed course.
You should have a good honours degree in a life sciences subject, although we will consider applicants with alternative qualifications and professional experience within the health service or other relevant background. You should either take An Introduction to Human Genetics and Genomics, Omics Techniques and their Application to Genomic Medicine) and Genomics in Cancer Pathology first, or be able to show you have equivalent knowledge and understanding to enable you to benefit from this module.
Please contact the Programme Administrator for further information at firstname.lastname@example.org